vs
Side-by-side financial comparison of Sempra (SRE) and Universal Health Services (UHS). Click either name above to swap in a different company.
Universal Health Services is the larger business by last-quarter revenue ($4.5B vs $3.7B, roughly 1.2× Sempra). Sempra runs the higher net margin — 31.5% vs 9.9%, a 21.5% gap on every dollar of revenue. On growth, Universal Health Services posted the faster year-over-year revenue change (9.1% vs -3.9%). Over the past eight quarters, Sempra's revenue compounded faster (21.3% CAGR vs 8.0%).
Sempra is a North American public utility holding company based in San Diego, California. The company is one of the largest utility holding companies in the United States with nearly 40 million consumers.
Universal Health Services, Inc. (UHS) is an American Fortune 500 company that provides hospital and healthcare services, based in King of Prussia, Pennsylvania. In 2024, UHS reported total revenues of $15.8 billion.
SRE vs UHS — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $3.7B | $4.5B |
| Net Profit | $1.1B | $445.9M |
| Gross Margin | — | — |
| Operating Margin | — | 11.5% |
| Net Margin | 31.5% | 9.9% |
| Revenue YoY | -3.9% | 9.1% |
| Net Profit YoY | 25.1% | 34.2% |
| EPS (diluted) | — | $7.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $3.7B | — | ||
| Q4 25 | $3.3B | $4.5B | ||
| Q3 25 | $2.8B | $4.5B | ||
| Q2 25 | $2.7B | $4.3B | ||
| Q1 25 | $3.7B | $4.1B | ||
| Q4 24 | $3.1B | $4.1B | ||
| Q3 24 | $2.6B | $4.0B | ||
| Q2 24 | $2.5B | $3.9B |
| Q1 26 | $1.1B | — | ||
| Q4 25 | $352.0M | $445.9M | ||
| Q3 25 | $95.0M | $373.0M | ||
| Q2 25 | $473.0M | $353.2M | ||
| Q1 25 | $917.0M | $316.7M | ||
| Q4 24 | $676.0M | $332.4M | ||
| Q3 24 | $649.0M | $258.7M | ||
| Q2 24 | $725.0M | $289.2M |
| Q1 26 | — | — | ||
| Q4 25 | 7.2% | 11.5% | ||
| Q3 25 | 10.6% | 11.6% | ||
| Q2 25 | 17.3% | 11.7% | ||
| Q1 25 | 21.5% | 11.1% | ||
| Q4 24 | 35.0% | 11.5% | ||
| Q3 24 | 12.9% | 9.7% | ||
| Q2 24 | 18.8% | 11.2% |
| Q1 26 | 31.5% | — | ||
| Q4 25 | 10.7% | 9.9% | ||
| Q3 25 | 3.4% | 8.3% | ||
| Q2 25 | 17.5% | 8.2% | ||
| Q1 25 | 24.9% | 7.7% | ||
| Q4 24 | 22.0% | 8.1% | ||
| Q3 24 | 25.3% | 6.5% | ||
| Q2 24 | 29.2% | 7.4% |
| Q1 26 | — | — | ||
| Q4 25 | $0.53 | $7.01 | ||
| Q3 25 | $0.12 | $5.86 | ||
| Q2 25 | $0.71 | $5.43 | ||
| Q1 25 | $1.39 | $4.80 | ||
| Q4 24 | $1.04 | $4.94 | ||
| Q3 24 | $1.00 | $3.80 | ||
| Q2 24 | $1.12 | $4.26 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $794.0M | $137.8M |
| Total DebtLower is stronger | $34.6B | $4.8B |
| Stockholders' EquityBook value | $39.5B | $7.3B |
| Total Assets | $113.5B | $15.5B |
| Debt / EquityLower = less leverage | 0.88× | 0.65× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $794.0M | — | ||
| Q4 25 | $29.0M | $137.8M | ||
| Q3 25 | $5.0M | $112.9M | ||
| Q2 25 | $155.0M | $137.6M | ||
| Q1 25 | $1.7B | $126.8M | ||
| Q4 24 | $1.6B | $126.0M | ||
| Q3 24 | $560.0M | $106.1M | ||
| Q2 24 | $228.0M | $128.8M |
| Q1 26 | $34.6B | — | ||
| Q4 25 | $29.0B | $4.8B | ||
| Q3 25 | $29.0B | $4.7B | ||
| Q2 25 | $34.9B | $4.6B | ||
| Q1 25 | $33.3B | $4.6B | ||
| Q4 24 | $31.6B | $4.5B | ||
| Q3 24 | $31.0B | $4.7B | ||
| Q2 24 | $29.0B | $4.5B |
| Q1 26 | $39.5B | — | ||
| Q4 25 | $31.6B | $7.3B | ||
| Q3 25 | $31.2B | $7.2B | ||
| Q2 25 | $31.7B | $7.0B | ||
| Q1 25 | $31.6B | $6.8B | ||
| Q4 24 | $31.2B | $6.7B | ||
| Q3 24 | $29.7B | $6.6B | ||
| Q2 24 | $29.5B | $6.5B |
| Q1 26 | $113.5B | — | ||
| Q4 25 | $110.9B | $15.5B | ||
| Q3 25 | $106.9B | $15.3B | ||
| Q2 25 | $99.9B | $15.0B | ||
| Q1 25 | $99.0B | $14.9B | ||
| Q4 24 | $96.2B | $14.5B | ||
| Q3 24 | $93.7B | $14.4B | ||
| Q2 24 | $90.5B | $14.1B |
| Q1 26 | 0.88× | — | ||
| Q4 25 | 0.92× | 0.65× | ||
| Q3 25 | 0.93× | 0.66× | ||
| Q2 25 | 1.10× | 0.65× | ||
| Q1 25 | 1.05× | 0.68× | ||
| Q4 24 | 1.01× | 0.68× | ||
| Q3 24 | 1.04× | 0.71× | ||
| Q2 24 | 0.98× | 0.69× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $420.0M | $574.7M |
| Free Cash FlowOCF − Capex | — | $293.5M |
| FCF MarginFCF / Revenue | — | 6.5% |
| Capex IntensityCapex / Revenue | 643.0% | 6.3% |
| Cash ConversionOCF / Net Profit | 0.37× | 1.29× |
| TTM Free Cash FlowTrailing 4 quarters | — | $849.2M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $420.0M | — | ||
| Q4 25 | $1.2B | $574.7M | ||
| Q3 25 | $1.1B | $380.7M | ||
| Q2 25 | $784.0M | $549.0M | ||
| Q1 25 | $1.5B | $360.0M | ||
| Q4 24 | $1.4B | $658.4M | ||
| Q3 24 | $1.0B | $333.0M | ||
| Q2 24 | $669.0M | $679.3M |
| Q1 26 | — | — | ||
| Q4 25 | $-2.2B | $293.5M | ||
| Q3 25 | $-1.5B | $151.8M | ||
| Q2 25 | $-1.5B | $283.0M | ||
| Q1 25 | $-854.0M | $121.0M | ||
| Q4 24 | $-1.1B | $412.5M | ||
| Q3 24 | $-913.0M | $85.0M | ||
| Q2 24 | $-1.2B | $437.9M |
| Q1 26 | — | — | ||
| Q4 25 | -67.7% | 6.5% | ||
| Q3 25 | -52.6% | 3.4% | ||
| Q2 25 | -56.3% | 6.6% | ||
| Q1 25 | -23.2% | 3.0% | ||
| Q4 24 | -35.4% | 10.0% | ||
| Q3 24 | -35.5% | 2.1% | ||
| Q2 24 | -49.4% | 11.2% |
| Q1 26 | 643.0% | — | ||
| Q4 25 | 104.0% | 6.3% | ||
| Q3 25 | 92.9% | 5.1% | ||
| Q2 25 | 85.3% | 6.2% | ||
| Q1 25 | 63.5% | 5.8% | ||
| Q4 24 | 79.9% | 6.0% | ||
| Q3 24 | 75.3% | 6.3% | ||
| Q2 24 | 76.4% | 6.2% |
| Q1 26 | 0.37× | — | ||
| Q4 25 | 3.38× | 1.29× | ||
| Q3 25 | 11.68× | 1.02× | ||
| Q2 25 | 1.66× | 1.55× | ||
| Q1 25 | 1.62× | 1.14× | ||
| Q4 24 | 2.02× | 1.98× | ||
| Q3 24 | 1.57× | 1.29× | ||
| Q2 24 | 0.92× | 2.35× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
SRE
Segment breakdown not available.
UHS
| Behavioral Health Services | $1.9B | 43% |
| Managed Care | $835.5M | 19% |
| Managed Medicare | $422.2M | 9% |
| Medicare | $396.3M | 9% |
| Medicaid | $353.7M | 8% |
| UK Revenue | $262.9M | 6% |
| Managed Medicaid | $175.9M | 4% |
| Other Patient Revenue And Adjustments Net | $137.1M | 3% |
